124
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Hydrothermal synthesis of antibacterial silver@cuprous oxide core-shell/hydroxyapatite (Ag@Cu2O/HAp) hetero-nanohybrids

, & ORCID Icon
Pages 263-277 | Received 01 Jun 2023, Accepted 16 Sep 2023, Published online: 04 Oct 2023
 

ABSTRACT

In the present work, we examined the antibacterial activity of novel silver@cuprous oxide core-shell/hydroxyapatite (Ag@Cu2O/HAp) hetero-nanohybrids against Gram-positive Staphylococcus aureus and Gram-negative Escherichia coli bacteria. The hydrothermal technique was used to easily synthesise Ag@Cu2O/HAp core-shell nanohybrid structures. Immobilisation of Ag@Cu2O core shells on HAp nanoparticles was done by controlling the relative concentrations of Ag, Cu2O, and HAp. The Ag@Cu2O/HAp nanohybrids were characterised using XRD, FTIR, Raman, UV-vis, SEM, EDX, TEM, and SAED methods. By observing the growth of S. aureus and E. coli populations in the presence and absence of Ag, Ag@Cu2O, HAp, and Ag@Cu2O/HAp nanoparticles, their antibacterial impact was compared. MIC Alamar Blue assay was performed to study the cytotoxicity of Ag@Cu2O/HAp nanomaterials. In addition, reactive oxygen species (ROS) studies were conducted to understand the type of active species produced under light and dark conditions. The possible photochemical and antibacterial mechanisms of the Ag@Cu2O/HAp nanohybrids against S. aureus and E. coli bacteria were proposed. In addition, the promising antibacterial nature of Ag@Cu2O/HAp materials suggests that they are good candidates for industrial and biomedical applications.

Graphical abstract

Acknowledgments

The authors thank Department of Materials Science, Central University of Tamil Nadu, Thiruvarur, Tamil Nadu 610005, India for providing the necessary facilities to complete the current work.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.